![Sari Laitinen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Sari Laitinen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Encorium Group, Inc.
![]() Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sari Laitinen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
iCeutica, Inc.
![]() iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Orion Pharma Oy
![]() Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President | |
University of Leiden | College/University | Graduate Degree | |
University of Helsinki | College/University | Doctorate Degree Graduate Degree | |
Paavo Nurmi Foundation | Corporate Secretary | ||
Encorium Oy | Director/Board Member | ||
SOCIETAL CDMO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
LZ Therapeutics, Inc.
![]() LZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LZ Therapeutics, Inc. develops novel differentiated products for the treatment of neurological disorders. It provides therapeutics to improve patient outcomes, including improved symptom control and potential disease modification. The company was founded by Jay S. Schneider in 2005 and is headquartered in Chester, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
LIPOCINE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aalto University School of Business | College/University | Masters Business Admin | |
Forendo Pharma Oy
![]() Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
BAUDAX BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
Finland | 9 |
United States | 8 |
Netherlands | 2 |
Sectoral
Health Technology | 11 |
Consumer Services | 4 |
Commercial Services | 2 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 5 |
Graduate Degree | 3 |
President | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Jyrki Pekka Sakari Mattila | 13 |
Petri Manninen | 6 |
- Stock Market
- Insiders
- Sari Laitinen
- Company connections